Affiliation:
1. Department of Medicinal Chemistry, Theodor Bilharz Research Institute, Warraq Al Hadar, Egypt
2. Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Warraq Al Hadar, Egypt
Abstract
Context:
Linum usitatissimum (Linn); known as Flaxseed, is one of the most important medicinal
plants traditionally used for health benefits and also as nutritional purposes.
Objective:
Estimation of total phenolic and flavonoid contents, and evaluation of the antioxidant, antiinflammatory
and anticancer activities have been performed on hexane, ethyl acetate, n-butanol, and
methanol extracts and also on fractions of methanol extract (hexane, ethyl acetate, and n-butanol).
Materials and Methods:
Phenolic and flavonoid contents were detected using spectrophotometric and
colorimetric assays. Antioxidant and anti-inflammatory activities were estimated in-vitro. Anticancer
activity of extracts was tested on Hepatocellular carcinoma cell line (HepG2) and breast cancer cell line
(MCF7).
Results:
The methanolic extract and its ethyl acetate fraction showed higher contents of total phenols
and flavonoids. Also, the methanolic extract showed a higher antioxidant activity. The butanolic and
ethyl acetate fractions at concentration 500μg/ml yielded a higher percent of inhibition of protein denaturation;
87.9% and 90%, respectively. The ethyl acetate fraction and the methanolic extract showed
an obvious anticancer activity against HepG2 and MCF7 (IC50=60±0.24 and 29.4±0.12μg. ml-1) and
(IC50=94.7±0.21 and 227±0.48μg. ml-1), respectively. The GC-MS analysis showed that the methanolic
extract had 32 compounds whereas the ethyl acetate and butanol fractions contained 40 and 36 compounds,
respectively.
Conclusion:
Flaxseed contains different biologically active compounds that have been found to possess
various activities, which can protect the human body against several diseases.
Publisher
Bentham Science Publishers Ltd.
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference47 articles.
1. Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424
2. Ziada D.H.; El Sadany S.; Soliman H.; Abd-Elsalam S.; Salama M.; Hawash N.; Selim A.; Hamisa M.; Elsabagh H.M.; Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study. J Egypt Natl Canc Inst 2016,28(4),257-262
3. Okasha H.; Hassan M.; Aboushousha T.; Samir S.;
Effect of Interferon- Beta (IFN-β) on tumor suppressor and apoptotic markers in hepatocellular carcinoma cell line. Int. J. Res. Pharm. Sci
2019,1610(4),2936-43
4. Toss A.; Cristofanilli M.; Molecular characterization and targeted therapeutic approaches in breast cancer Breast Cancer Res, 2015,17(1),60
5. Azim H.A.; Ibrahim A.S.; Breast cancer in Egypt, China and Chinese: Statistics and beyond. J Thorac Dis 2014,6(7),864-866
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献